Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value:
$532.10M
Total Bought:
$251.65M
Total Sold:
$213.15M
Net Transaction:
+$38.50M
Notable People:
Catalio Capital Gp, Llc
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
AVALYN PHARMACEUTICALS INC01,675,830+1,675,830$0$55.17M10.37%+$55.17M
Johnson & Johnson(JNJ)0138,946+138,946$0$35.29M6.63%+$35.29M
Gilead Sciences, Inc.(GILD)163,905269,309+105,404$22.84M$34.02M6.39%+$11.18M
BridgeBio Pharma, Inc.(BBIO)432,014455,041+23,027$32.08M$33.89M6.37%+$1.81M
Syndax Pharmaceuticals, Inc.(SNDX)1,043,6701,215,698+172,028$24.38M$26.58M4.99%+$2.20M
Definium Therapeutics, Inc.(DFTX)1,037,984562,672-475,312$19.62M$26.47M4.97%+$6.85M
Bristol-Myers Squibb Company(BMY)420,727412,961-7,766$25.52M$23.79M4.47%-$1.72M
PARABILIS MEDICINES INC0824,043+824,043$0$22.55M4.24%+$22.55M
Natera, Inc.(NTRA)70,90782,181+11,274$14.18M$22.31M4.19%+$8.13M
Incyte Corporation(INCY)182,101191,627+9,526$17.14M$21.72M4.08%+$4.58M
Septerna, Inc.(SEPN)294,360536,152+241,792$7.07M$17.96M3.37%+$10.88M
Mineralys Therapeutics, Inc.(MLYS)439,041648,722+209,681$11.89M$17.50M3.29%+$5.61M
Heartflow, Inc.(HTFL)403,588583,055+179,467$9.82M$17.11M3.21%+$7.29M
Corvus Pharmaceuticals, Inc.(CRVS)891,9331,080,888+188,955$13.05M$16.15M3.03%+$3.10M
STRUCTURE THERAPEUTICS INC255,379276,550+21,171$12.31M$14.84M2.79%+$2.53M
PROTAGONIST THERAPEUTICS INC0106,799+106,799$0$13.09M2.46%+$13.09M
Disc Medicine, Inc.(IRON)122,978159,384+36,406$7.86M$11.66M2.19%+$3.79M
EDWARDS LIFESCIENCES CORP144,607124,778-19,829$11.58M$11.29M2.12%-$292.7K
Axsome Therapeutics, Inc.(AXSM)043,182+43,182$0$10.57M1.99%+$10.57M
Ultragenyx Pharmaceutical Inc.(RARE)850,797316,252-534,545$17.82M$10.56M1.98%-$7.26M
KAILERA THERAPEUTICS INC0468,750+468,750$0$10.33M1.94%+$10.33M
KARYOPHARM THERAPEUTICS INC897,709940,855+43,146$5.00M$9.19M1.73%+$4.19M
ODYSSEY THERAPEUTICS INC0457,839+457,839$0$8.57M1.61%+$8.57M
Ascendis Pharma A/S(ASND)031,759+31,759$0$8.47M1.59%+$8.47M
KARDIGAN INC0312,500+312,500$0$7.45M1.40%+$7.45M
ELEDON PHARMACEUTICALS INC1,639,8161,695,071+55,255$5.05M$6.68M1.26%+$1.63M
4D MOLECULAR THERAPEUTICS IN0471,254+471,254$0$6.27M1.18%+$6.27M
Veradermics, Incorporated(MANE)173,58245,856-127,726$10.96M$5.64M1.06%-$5.32M
Dyne Therapeutics, Inc.(DYN)282,954244,929-38,025$5.13M$5.44M1.02%+$309.9K
FRACTYL HEALTH INC5,491,8666,168,749+676,883$2.51M$4.90M0.92%+$2.39M
Immunocore Holdings plc(IMCR)84,352148,045+63,693$2.54M$4.70M0.88%+$2.16M
Dianthus Therapeutics, Inc.(DNTH)560,30832,941-527,367$47.02M$3.21M0.60%-$43.81M
BRIDGEBIO ONCOLOGY THERAPEUT0318,407+318,407$0$2.43M0.46%+$2.43M
PROTARA THERAPEUTICS INC580,024520,148-59,876$3.02M$1.99M0.37%-$1.03M
HYPERFINE INC1,320,0411,320,0410$1.43M$1.78M0.33%+$356.4K
ATAIBECKLEY INC196,858196,8580$696.9K$1.04M0.19%+$340.6K
METAGENOMI THERAPEUTICS INC528,993528,9930$708.9K$629.5K0.12%-$79.3K
OUTSET MED INC118,279118,2790$454.2K$511.0K0.10%+$56.8K
FAETH THERAPEUTICS INC14,71814,7180$463.9K$367.9K0.07%-$96.0K
ABIVAX Société Anonyme(ABVX)47,1930-47,193$5.25M$0—-$5.25M
Adaptive Biotechnologies Corporation(ADPT)722,7840-722,784$10.03M$0—-$10.03M
Ascendis Pharma A/S(ASND)129,1110-129,111$29.53M$0—-$29.53M
Boston Scientific Corporation(BSX)299,3180-299,318$18.78M$0—-$18.78M
Cytokinetics, Incorporated(CYTK)215,5010-215,501$14.20M$0—-$14.20M
KALVISTA PHARMACEUTICALS INC426,5510-426,551$8.59M$0—-$8.59M
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
83,5540-83,554$2.67M$0—-$2.67M
PHATHOM PHARMACEUTICALS INC247,7670-247,767$2.75M$0—-$2.75M
uniQure N.V.(QURE)491,1160-491,116$8.03M$0—-$8.03M
SOLENO THERAPEUTICS INC577,8080-577,808$19.35M$0—-$19.35M
Supernus Pharmaceuticals, Inc.(SUPN)62,0190-62,019$3.21M$0—-$3.21M
TERNS PHARMACEUTICALS INC409,0310-409,031$21.56M$0—-$21.56M
Tyra Biosciences, Inc.(TYRA)67,2850-67,285$2.58M$0—-$2.58M
Page 1 of 1